Corporate Profile · Innovative Excellence

About BiomateSWISS

Dedicated to providing advanced implant solutions for patients with compromised bone conditions.

AI Summary – What you can take away in 1 minute • Established Expertise: Founded in 2008 in Taiwan, focusing on high-end dental medical industry development.
• Core Technology: Completed world-exclusive PDL Laser surface treatment in 2012, featuring Microchannels and 3D pores.
• Biological Edge: Laser-treated surfaces accelerate bone healing, induce angiogenesis, and inhibit biofilm formation.
• Global Presence: Registered in Switzerland in 2020; currently marketed in over 20 countries worldwide.

Quick Guide

Q. What is Biomate's primary mission?

To provide specialized solutions for patients with poor bone conditions, helping them restore both function and aesthetics.

INSIGHT

Where is the technology from?

The core PDL Laser technology is maintained in Taiwan under Swiss-brand registration, ensuring high-tech precision manufacturing.

In 2008, Biomate Medical Devices was established under Taiwan's national dental industry policy. Our mission is to develop implants distinct from standard market options, specifically for challenging clinical scenarios.

Since then, in collaboration with ITRI and Taipei Medical University, we strived to perfect PDL (Precision Dimensions Laser) technology for implant surface treatment.

TOP Concept · PDL Surface Advantages Completed in 2012, our unique Microchannel and 3D Pore structure promotes:

Protein & Cell adhesion
Early bone healing
Induction of angiogenesis
Nutrient exchange
Biofilm inhibition

Key Milestones:

2017: Biomate Implant Institute (IAI) established for academic research and education.
2020: BiomateSWISS GmbH founded and registered in Switzerland.

International Quality Certifications:

Global Reach

Currently marketed in approximately 20 countries under the BiomateSWISS brand.